Tybourne Capital Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,906,629
Closed -$7.18M 7
2025
Q1
$7.18M Hold
2,906,629
30.48% 1
2024
Q4
$9.13M Hold
2,906,629
2.29% 14
2024
Q3
$14.3M Hold
2,906,629
4.02% 9
2024
Q2
$12.8M Hold
2,906,629
2.61% 13
2024
Q1
$19.6M Hold
2,906,629
3.35% 14
2023
Q4
$21.7M Buy
2,906,629
+676,187
+30% +$5.77M 3.23% 15
2023
Q3
$22.7M Hold
2,230,442
3.17% 14
2023
Q2
$46.6M Buy
+2,230,442
New +$45.6M 5.04% 8

Other funds holding SLRN

Tybourne Capital Management's SLRN Position: Q2 2025 in Review

Tybourne Capital Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 2,906,629 shares — an estimated $7.18M sold.

Tybourne Capital Management first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $46.6M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Tybourne Capital Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Tybourne Capital Management sold 2,906,629 ACELYRIN shares in Q2 2025, an estimated $7.18M.
  • Tybourne Capital Management first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
  • Tybourne Capital Management's ACELYRIN position peaked at $46.6M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Tybourne Capital Management's 13F filing for Q2 2025, filed 1 Aug 2025.